Eosinophils in Bullous Pemphigoid
大疱性类天疱疮中的嗜酸性粒细胞
基本信息
- 批准号:10198769
- 负责人:
- 金额:$ 36.76万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2017
- 资助国家:美国
- 起止时间:2017-07-24 至 2023-06-30
- 项目状态:已结题
- 来源:
- 关键词:AdultAnimal ModelApplications GrantsAutoantibodiesAutoimmuneAutoimmunityBindingBiological MarkersBullaBullous PemphigoidCC chemokine receptor 3CellsCharacteristicsChemotactic FactorsChymaseComplementDataDermalDevelopmentDiseaseEotaxinExtracellular DomainGelatinase BGoalsHomologous GeneHumanIgEIgE ReceptorsIgG autoantibodiesImmuneImmunoglobulin GIn VitroInfiltrationInflammationInflammatory InfiltrateInnate Immune SystemLesionLiquid substanceLymphocyteMediatingModelingMouse StrainsMusNatural ImmunityNeutrophil InfiltrationParticipantPatientsPeptide HydrolasesPositioning AttributeProteinsResearchResistanceRoleSerumSiteSkinSkin TissueStainsStudy modelsTestingTranslatingcell typedisease mechanisms studyeffective therapyeosinophileotaxin receptorhumanized mousein vivoinnate immune functionkeratinocytemacrophagemast cellmouse modelneutrophilpreclinical studypreclinical trialrecruitskin disordertissue injury
项目摘要
Project Summary
Bullous pemphigoid (BP) is an autoimmune subepidermal blistering disease characterized by autoantibodies
and an inflammatory infiltrate at the lesional site. BP autoantibodies belong to IgG and IgE isotypes and
recognize two hemidesmosomal proteins, BP180 and BP230. These autoantibodies mainly target the NC16A
extracellular domain of BP180. The dermal infiltrate contains eosinophils, neutrophils, mast cells, macrophage
and lymphocytes, with eosinophils being the predominant cell type. The roles of anti-BP180 IgG autoantibodies
and neutrophils in BP have been extensively investigated. In vitro and in vivo studies have demonstrated that
anti-BP180 NC16A IgG autoantibodies fix complement, recruit neutrophils and cause BP-like blisters.
However, roles of anti-BP180 IgE and eosinophils in BP remain largely unknown. Lack of a suitable animal
model is a major obstacle for studies of IgE and eosinophils because human IgE do not recognize mouse IgE
receptors. Our lab currently developed a double humanized mouse stain (termed hFcεRI/NC16A mice), in
which the human NC16A domain replaced the mouse counterpart NC14A domain and human FcεRI are
expressed on eosinophils and mast cells. More significantly, adult hFcεRI/NC16A mice injected with anti-
NC16A IgE autoantibodies from BP patients develop BP skin disease that required eosinophils and mast cells.
The objective of this proposal is to study the role of eosinophils and mast cells in BP using our newly
developed hFcεRI/NC16A mouse model. The overall goal of this project is to increase our understanding of the
innate immunity of BP and how it relates to the functions of innate immune system players in inflammation and
autoimmunity. In this grant proposal, we will determine how eosinophils are recruited and functionally interact
with mast cells (Aims 1 and 2). Proteolytic enzymes from these innate immune cells are critical for skin tissue
injury, therefore, we will translate our animal model findings to human BP (Aim 3). Since this proposal
integrates both disease mechanism studies and preclinical trials, the findings are expected to have a significant
impact on the treatment of patients with BP.
项目摘要
大疱性类天疱疮是一种以自身抗体为特征的自身免疫性表皮下水疱性疾病
以及病变部位的炎症浸润BP自身抗体属于IgG和IgE同种型,
识别两种半桥粒蛋白,BP 180和BP 230。这些自身抗体主要靶向NC 16 A
BP 180的胞外结构域。真皮浸润物含有嗜酸性粒细胞、中性粒细胞、肥大细胞、巨噬细胞
和淋巴细胞,嗜酸性粒细胞是主要的细胞类型。抗BP 180 IgG自身抗体的作用
BP中的中性粒细胞已得到广泛研究。体外和体内研究表明,
抗BP 180 NC 16 A IgG自身抗体固定补体,募集嗜中性粒细胞并引起BP样水疱。
然而,抗BP 180 IgE和嗜酸性粒细胞在BP中的作用在很大程度上仍然未知。缺乏合适的动物
模型是IgE和嗜酸性粒细胞研究的主要障碍,因为人IgE不能识别小鼠IgE
受体。我们的实验室目前开发了一种双重人源化小鼠染色剂(称为hFcεRI/NC 16 A小鼠),
其中人NC 16 A结构域取代小鼠对应物NC 14 A结构域,并且人FcεRI是
在嗜酸性粒细胞和肥大细胞上表达。更重要的是,成年hFcεRI/NC 16 A小鼠注射抗-
来自BP患者的NC 16 A IgE自身抗体发展为需要嗜酸性粒细胞和肥大细胞的BP皮肤病。
本建议的目的是研究嗜酸性粒细胞和肥大细胞在BP中的作用,
建立hFcεRI/NC 16 A小鼠模型。这个项目的总体目标是增加我们对
BP的先天免疫以及它如何与先天免疫系统参与者在炎症和
自身免疫在这个拨款申请中,我们将确定嗜酸性粒细胞是如何被招募和功能性相互作用的。
肥大细胞(目的1和2)。来自这些先天免疫细胞的蛋白水解酶对皮肤组织至关重要
因此,我们将把我们的动物模型发现转化为人类BP(目标3)。由于这一提议
整合了疾病机制研究和临床前试验,这些发现预计将具有重大意义。
对BP患者的治疗有影响。
项目成果
期刊论文数量(1)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
The Autoimmune Skin Disease Bullous Pemphigoid: The Role of Mast Cells in Autoantibody-Induced Tissue Injury.
- DOI:10.3389/fimmu.2018.00407
- 发表时间:2018
- 期刊:
- 影响因子:7.3
- 作者:Fang H;Zhang Y;Li N;Wang G;Liu Z
- 通讯作者:Liu Z
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Zhi Liu其他文献
Zhi Liu的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Zhi Liu', 18)}}的其他基金
Development of a salt-based nanomedicine for non-muscle invasive bladder cancer
开发用于非肌肉浸润性膀胱癌的盐基纳米药物
- 批准号:
10482565 - 财政年份:2022
- 资助金额:
$ 36.76万 - 项目类别:
Development of a radiation-activatable nanoparticle for lung cancer therapy
开发用于肺癌治疗的辐射激活纳米颗粒
- 批准号:
10259278 - 财政年份:2021
- 资助金额:
$ 36.76万 - 项目类别:
Inflammasome-gasdermin axis in bullous pemphigoid
大疱性类天疱疮的炎症小体-gasdermin轴
- 批准号:
10382402 - 财政年份:2018
- 资助金额:
$ 36.76万 - 项目类别:
Inflammasome-gasdermin axis in bullous pemphigoid
大疱性类天疱疮的炎症小体-gasdermin轴
- 批准号:
9899921 - 财政年份:2018
- 资助金额:
$ 36.76万 - 项目类别:
相似海外基金
Quantification of Neurovasculature Changes in a Post-Hemorrhagic Stroke Animal-Model
出血性中风后动物模型中神经血管变化的量化
- 批准号:
495434 - 财政年份:2023
- 资助金额:
$ 36.76万 - 项目类别:
Bioactive Injectable Cell Scaffold for Meniscus Injury Repair in a Large Animal Model
用于大型动物模型半月板损伤修复的生物活性可注射细胞支架
- 批准号:
10586596 - 财政年份:2023
- 资助金额:
$ 36.76万 - 项目类别:
A Comparison of Treatment Strategies for Recovery of Swallow and Swallow-Respiratory Coupling Following a Prolonged Liquid Diet in a Young Animal Model
幼年动物模型中长期流质饮食后吞咽恢复和吞咽呼吸耦合治疗策略的比较
- 批准号:
10590479 - 财政年份:2023
- 资助金额:
$ 36.76万 - 项目类别:
Small animal model for evaluating the impacts of cleft lip repairing scar on craniofacial growth and development
评价唇裂修复疤痕对颅面生长发育影响的小动物模型
- 批准号:
10642519 - 财政年份:2023
- 资助金额:
$ 36.76万 - 项目类别:
Diurnal grass rats as a novel animal model of seasonal affective disorder
昼夜草鼠作为季节性情感障碍的新型动物模型
- 批准号:
23K06011 - 财政年份:2023
- 资助金额:
$ 36.76万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Longitudinal Ocular Changes in Naturally Occurring Glaucoma Animal Model
自然发生的青光眼动物模型的纵向眼部变化
- 批准号:
10682117 - 财政年份:2023
- 资助金额:
$ 36.76万 - 项目类别:
A whole animal model for investigation of ingested nanoplastic mixtures and effects on genomic integrity and health
用于研究摄入的纳米塑料混合物及其对基因组完整性和健康影响的整体动物模型
- 批准号:
10708517 - 财政年份:2023
- 资助金额:
$ 36.76万 - 项目类别:
A Novel Large Animal Model for Studying the Developmental Potential and Function of LGR5 Stem Cells in Vivo and in Vitro
用于研究 LGR5 干细胞体内外发育潜力和功能的新型大型动物模型
- 批准号:
10575566 - 财政年份:2023
- 资助金额:
$ 36.76万 - 项目类别:
Elucidating the pathogenesis of a novel animal model mimicking chronic entrapment neuropathy
阐明模拟慢性卡压性神经病的新型动物模型的发病机制
- 批准号:
23K15696 - 财政年份:2023
- 资助金额:
$ 36.76万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
The effect of anti-oxidant on swallowing function in an animal model of dysphagia
抗氧化剂对吞咽困难动物模型吞咽功能的影响
- 批准号:
23K15867 - 财政年份:2023
- 资助金额:
$ 36.76万 - 项目类别:
Grant-in-Aid for Early-Career Scientists














{{item.name}}会员




